Omkar Pharmachem Ltd
₹7.91▼ -0.41 (-4.93%)
OMKARPH·BSE·Chemicals
Market Cap
7.97 Cr
PE Ratio
65.92
Volume
200
Day High - Low
7.92 - 7.91
52W High-Low
29.74 - 7.08
₹7.91▼ -0.41 (-4.93%)
Market Cap7.97 Cr
PE Ratio65.92
Volume200
Day High - Low7.92 - 7.91
52W High-Low29.74 - 7.08
Omkar Pharmachem Ltd (OMKARPH): company summary
The company's business has declined, with annual revenue falling 13.0% and annual net profit dropping 40.0%.
Omkar Pharmachem Ltd (OMKARPH) is a micro-cap Chemicals company valued at ₹8 crore operating in Commodity Chemicals on the NSE and BSE.
- Recent price move
- Omkar Pharmachem Ltd last traded at ₹7.91, down 4.93% on the day.
- Financial performance
- The company's business has declined, with annual revenue falling 13.0% and annual net profit dropping 40.0%. The latest quarter shows a loss of ₹0 crore, reversing from a net profit of ₹0 crore in the same quarter a year earlier.
- Valuation multiples
- The stock trades at 65.9 times earnings, 0.21 times book value.
- Things to watch
- The company has reported a loss in the latest quarter, and net profit margin has fallen 11.0 percentage points to 26.2%. The stock is 72.0% below its 52-week high, and the company has not generated any revenue or profit in the latest quarter or fiscal year.
- Where it stands
- Omkar Pharmachem Ltd has not reported any revenue or profit in the latest quarter or fiscal year, with net profit margin declining to 26.2%. The stock is 72.0% below its 52-week high, and the company's financials show a continued decline in profitability.
Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
DocStoX Score
4.6/10
Weak
Fair Value
Sign in to see
ROE
0.33%
Weak
P/E
65.92x
Expensive
Debt / Equity
0.00
Low
Industry
Chemicals
Commodity Chemicals
Overall View
Mixed
Price performance
Day₹7.91
₹7.92
52W₹7.08
₹29.74
DocStoX take
Supported by risk (8.9), but held back by momentum (0.0). Risk looks strong at 8.9, but that is offset by momentum at 0.0 and growth at 1.9. We are calling it Mixed rather than resolving the conflict for you.
DocStoX score
Low confidence4.6
/10
Weak
Quality
Solid
ROE 0.3%
Valuation
Fair
P/E 65.9×
Growth
Flat
Revenue +11.7% 5Y CAGR
Risk
Low risk
D/E 0.00
Momentum
Weak
4% of 52-week range
At a glance
Market Cap
₹8 Cr
52W High / Low
₹30 / ₹7
Dividend Yield
0.00%
Promoter Holding
0.03%
EPS (TTM)
₹0.12
Book Value
₹36.34
Key highlights
- Low leverage — D/E 0.00
- Profitable in all of the last 5 years
- Healthy net margin (26%)
- Profit shrinking 11% a year
- Growth is weak (1.9/10)
3 Positives4 Watchouts
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Chemicals stocks · Commodity Chemicals
Explore Omkar Pharmachem Ltd’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Omkar Pharmachem Ltd peers in Chemicals
Other Chemicals stocks on the NSE & BSE. See the full Chemicals sector list.
Related tools & concepts
Value Omkar Pharmachem Ltd with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing